(Q46438027)

22 December 2017

title

Individual change in methylphenidate use in a national sample of children aged 2 to 11 years (English)

1 reference

22 December 2017

3

Isabel Fortier

1 reference

22 December 2017

7

Richard E Tremblay

1 reference

22 December 2017

author name string

Elisa Romano

1

1 reference

22 December 2017

Raymond H Baillargeon

2

1 reference

22 December 2017

Hong-Xing Wu

4

1 reference

22 December 2017

Philippe Robaey

5

1 reference

22 December 2017

Mark Zoccolillo

6

1 reference

22 December 2017

language of work or name

English

0 references

publication date

1 March 2005

1 reference

22 December 2017

Canadian Journal of Psychiatry

published in

1 reference

22 December 2017

volume

50

1 reference

22 December 2017

issue

3

1 reference

22 December 2017

page(s)

144-152

1 reference

22 December 2017

Attention-deficit hyperactivity disorder in Manitoba children: medical diagnosis and psychostimulant treatment rates

cites work

1 reference

https://api.crossref.org/works/10.1177%2F070674370505000303

Prevalence of methylphenidate use and change over a two-year period: a nationwide study of 2- to 11-year-old Canadian children

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370505000303

National trends in the prevalence of attention-deficit/hyperactivity disorder and the prescribing of methylphenidate among school-age children: 1990-1995.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370505000303

Trends in the prescribing of psychotropic medications to preschoolers

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370505000303

Psychotropic practice patterns for youth: a 10-year perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370505000303

Are stimulants overprescribed? Treatment of ADHD in four U.S. communities

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370505000303

Prevalence of medication treatment for attention deficit-hyperactivity disorder among elementary school children in Johnston County, North Carolina.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370505000303

Stimulant treatment in Maryland public schools

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370505000303

A double-blind, placebo-controlled study of modified-release methylphenidate in children with attention-deficit/hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370505000303

Double-blind methylphenidate trials: practical, useful, and highly endorsed by families.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370505000303

Developmental aspects of psychostimulant treatment in children and adolescents with attention-deficit/hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370505000303

Findings from the NIMH Multimodal Treatment Study of ADHD (MTA): implications and applications for primary care providers

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370505000303

Preschool attention deficit hyperactivity disorder: a review of prevalence, diagnosis, neurobiology, and stimulant treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370505000303

Methylphenidate in children with hyperactivity: review and cost-utility analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370505000303

21 January 2018

Stimulant medications

1 reference

https://api.crossref.org/works/10.1177%2F070674370505000303

Predictors of long-term outcome in children with attention-deficit/hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370505000303

Pharmacotherapy of attention-deficit hyperactivity disorder across the life cycle

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370505000303

Practice parameter for the use of stimulant medications in the treatment of children, adolescents, and adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370505000303

Long-term use of stimulants in children with attention deficit hyperactivity disorder: safety, efficacy, and long-term outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370505000303

Clinical practice guideline: treatment of the school-aged child with attention-deficit/hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370505000303

Quebec child mental health survey: prevalence of DSM-III-R mental health disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370505000303

Ontario Child Health Study. II. Six-month prevalence of disorder and rates of service utilization

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370505000303

Prevalence of attention-deficit/hyperactivity disorder symptoms in 4- to 17-year-old children in the general population

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370505000303

Ontario Child Health Study: prevalence of attention deficit disorder with hyperactivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370505000303

Comparison of diagnostic criteria for attention-deficit hyperactivity disorder in a county-wide sample

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370505000303

Developmental trajectories of childhood disruptive behaviors and adolescent delinquency: a six-site, cross-national study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370505000303

Childhood behavioral profiles leading to adolescent conduct disorder: risk trajectories for boys and girls.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370505000303

Trajectories of boys' physical aggression, opposition, and hyperactivity on the path to physically violent and nonviolent juvenile delinquency.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370505000303

The use of methylphenidate in Michigan

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370505000303

Prevalence variations in psychotropic treatment of children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370505000303

10.1177/070674370505000303

21 January 2018

Identifiers

DOI

1 reference

22 December 2017

1 reference

22 December 2017